Biomedical Engineering Reference
In-Depth Information
88. Hong, K.,
., Stabilization of cationic liposome-plasmid DNA
complexes by polyamines and poly(ethylene glycol)-phospholipid
conjugates for efficient
et al
in vivo
gene delivery.
FEBS Lett
, 1997.
400
(2):
pp. 233-237.
89. Liu, Y.,
., Factors influencing the efficiency of cationic liposome-
mediated intravenous gene delivery.
et al
Nat Biotechnol
, 1997.
15
(2):
pp. 167-173.
90. Semple, S.C., A. Chonn, and P.R. Cullis, Influence of cholesterol on the
association of plasma proteins with liposomes.
Biochemistry
, 1996.
(8): pp. 2521-2525.
91. Crook, K.,
35
., Inclusion of cholesterol in DOTAP transfection
complexes increases the delivery of DNA to cells
et al
in vitro
in the presence
of serum.
Gene Ther
, 1998.
5
(1): pp. 137-143.
92. Li, S.D.,
., Tumor-targeted delivery of siRNA by self-assembled
nanoparticles.
et al
Mol Ther
, 2008.
16
(1): pp. 163-169.
93. Bolcato-Bellemin, A.L.,
et al
., Sticky overhangs enhance siRNA-
mediated gene silencing.
Proc Natl Acad Sci USA
, 2007.
104
(41):
pp. 16050-16055.
94. Li, S., and L. Huang,
gene transfer via intravenous administration
of cationic lipid-protamine-DNA (LPD) complexes.
In vivo
Gene Ther
, 1997.
(9): pp. 891-900.
95. Li, S.D., and L. Huang, Targeted delivery of antisense oligodeoxynuc-
leotide and small interference RNA into lung cancer cells.
4
Mol Pharm
,
(5): pp. 579-588.
96. Silvander, M., M. Johnsson, and K. Edwards, Effects of PEG-lipids on
permeability of phosphatidylcholine/cholesterol liposomes in buffer
and in human serum.
2006.
3
(1): pp. 15-26.
97. Brannon-Peppas, L., and J.O. Blanchette, Nanoparticle and targeted
systems for cancer therapy.
Chem Phys Lipids
, 1998.
97
Adv Drug Deliv Rev
, 2004.
56
(11):
pp. 1649-1659.
98. John, C.S.,
et al
., Targeting sigma receptor-binding benzamides as
in
vivo
diagnostic and therapeutic agents for human prostate tumors.
Cancer Res
, 1999.
59
(18): pp. 4578-4583.
99. John, C.S.,
pharmacologic characterization,
and preclinical evaluation of N-[2-(1
et al
., Synthesis,
in vitro
′
-piperidinyl)ethyl]-3-[125I]iodo-
4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
Nucl
Med Biol
, 1999.
26
(4): pp. 377-382.
Search WWH ::
Custom Search